Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT05931224 Completed - Clinical trials for Essential Hypertension

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Start date: June 28, 2023
Phase: Phase 3
Study type: Interventional

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

NCT ID: NCT05684666 Completed - Clinical trials for Essential Hypertension

Effect of Breathing and Muscle Relaxation Technique in Individual With Essential Hypertension

Start date: February 21, 2019
Phase: N/A
Study type: Interventional

Primary hypertension, also called essential hypertension, is a rise in blood pressure (BP) with no identifiable cause. The most prevalent form of hypertension is essential hypertension, which involves 95% of patients with hypertension.Progressive muscle relaxation (PMR) is learning to relax some groups of muscles while paying attention to the feelings connected with both the tense and relaxed states.It is generally established that regular slow (deep) breathing exercises enhance respiratory and cardiovascular function by enhancing parasympathetic tone and reducing sympathetic activity, thus reducing BP, heart rate, respiratory rate, and stress levels in hypertensive patients. This study aimed to investigate the combined effect of slow breathing and PMR technique on BP, heart rate, respiratory rate, and anxiety in patients diagnosed with essential hypertension.

NCT ID: NCT05661721 Completed - Clinical trials for Hypertension,Essential

Licorice and Home Blood Pressure

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

Out-of-office blood pressure is more strongly associated with cardiovascular risk than office blood pressure. Licorice is known to raise blood pressure, but no previous studies have measured the effects on home blood pressure. The aim of this study is to analyze the association between licorice intake and home blood pressure.

NCT ID: NCT05631990 Completed - Clinical trials for Hypertension, Essential

A Study to Evaluate the Efficacy and Safety of AD-209

Start date: April 5, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of AD-209

NCT ID: NCT05513430 Completed - Clinical trials for Hypertension,Essential

Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Start date: June 16, 2014
Phase:
Study type: Observational

Study is an observational study among hypertensive patients

NCT ID: NCT05476354 Completed - Clinical trials for Essential Hypertension

Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

Start date: July 5, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of Irbesartan and Amlodipine combined therapy in patients with essential hypertension inadequately controlled on Irbesartan monotherapy

NCT ID: NCT05476120 Completed - Clinical trials for Essential Hypertension

The Effect of the Use of BATHE Interview Technique on Treatment Compliance in Hypertension Patients in Primary Care

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The research is planned to evaluate the treatment compliance after the BATHE interview technique in hypertension patients.

NCT ID: NCT05475665 Completed - Clinical trials for Essential Hypertension

Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

Start date: July 14, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of Irbesartan and Amlodipine combined therapy in patients with essential hypertension inadequately controlled on Irbesartan monotherapy

NCT ID: NCT05462535 Completed - Clinical trials for Hypertension,Essential

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Start date: February 26, 2018
Phase:
Study type: Observational

This study was to evaluate the therapeutic effect and safety of Amosartan Plus tablet administration in uncontrolled essential hypertension patients. During the routine medical visit, Amosartan Plus tablets were administered to patients in need of blood pressure control according to the investigator's judgment. In this study, effectiveness and safety information of treatment of Amosartan Plus tablets was followed for 6 months (up to 12 months), and observation of the target patients was terminated after collecting relevant data. As this study was a non-interventional observational study, all patients received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.

NCT ID: NCT05450601 Completed - Hypertension Clinical Trials

A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients

Start date: September 1, 2022
Phase: Phase 3
Study type: Interventional

A multicenter, randomized, double-blind, phase III study to evaluate the efficacy and safety of HCP2102 in patients with essential hypertension